QSAM Biosciences, Inc. Banner Image

QSAM Biosciences, Inc.

  • Ticker QSAM
    Exchange OTC More
  • Industry Biotechnology More
  • Sector Healthcare More
QSAM Biosciences, Inc. Logo Image
  • 1-10 Employees
  • Based in Austin, Texas
QSAM Biosciences, Inc. is developing next-generation nuclear medicines for the treatment of cancer and other diseases. QSAM’s initial technology, CycloSam® (Samarium-153 DOTMP), is a clinical-stage bone-targeting radiopharmaceutical developed by IsoTherapeutics Group LLC, pioneers in the nuclear medicine space who also developed the FDA-approved Quadramet® (Samarium-153 EDTMP), which isMore indicated for bone cancer pain palliation. QSAM is led by an experienced executive team and board of directors that have completed numerous FDA approvals and multiple successful biotech exits.
QSAM Biosciences, Inc.

Most Recent Annual Report

QSAM Biosciences, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

QSAM Biosciences, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!